Crossmark

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort

Crossref DOI link: https://doi.org/10.1136/bmjresp-2020-000758

Published Online: 2021-05-05

Published Print: 2021-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

de Boer, Geertje https://orcid.org/0000-0002-9615-1123
Braunstahl, Gert-Jan https://orcid.org/0000-0001-7671-3742
Hendriks, Rudi https://orcid.org/0000-0003-2291-0382
Tramper-Stranders, Gerdien https://orcid.org/0000-0002-0228-5375
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03278561 at ClinicalTrials.gov

Documents that mention this clinical trial

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
https://doi.org/10.1136/bmjresp-2020-000758
License Information

License valid from 2021-05-05